S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:50 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

GENB

Generate Biomedicines, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
16.39
+0.05 +0.31%
USD · close Sep 4

One year, everything drawn on

132 SESSIONS · DAILY CLOSES
21181410Sep 1 · Director sell $16KAug 6 · 10-Q filed (Q2 2026)Aug 6 · 10-Q filed (Q1 2026)Aug 6 · 10-Q filed (Q2 2025)Aug 6 · 10-Q filed (Q1 2025)FEB 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-06
Insiders (90d): $16K net selling
Shorts (latest report): 7.3M short · +11K last period
Every line of the math
50WATCH

Congress is trading it

No STOCK Act disclosure names GENB.

Insider activity

ALL 1
DateInsiderTypeValue
Sep 1DirectorSell$16K
Watch GENB. Know when insiders buy.
One email the day a filing lands. Free.